Ann: Non-Executive Director appointment and retirement, page-12

2 new experienced Pharma directors well qualified with an impressive track records hopefully might help E4 get of the ground ( no shares held reported) . Outgoing director Nancy Dolan ( member of audit and risk committee ) regardless of directors obligation to report a change in share holding within 5 business day's flogged off her large holding $1 M ? before the bottom dropped out while back now , pretty sure never reported selling . Conveniently our recently resigned ( ex directors now not obliged to report off loading ) BM ans RC quite likely selling off their massive share holding in whats become a high risk investment , these insiders who better to know the odds of success than them . Chairman Frank Condella very modest holding , purchased $136 ,000 9/21 .33 purchased $37,000 9/20 .35 These people and others in senior management who got us into this precarious position make or break situation totally reliant of Nexstellis if this thing turns pear shaped apart from them losing their mostly under deserved employment ( going by our performance) have little or nothing to lose Retail holders especially on high averages taking all the risk here .